Sulforaphane enhances cellular antioxidant levels by activation of the Nrf2/ARE pathway, resulting in the upregulation of phase II antioxidant enzymes HO-1 and Gpx1 [12], both of which have been found to have neuroprotective actions during brain inflammation [32], [13], [20]. Here, GPX1 is linked to brain inflammatory disease.